Defining the use of anti-PrP monoclonal antibodies in a mouse model of prion disease
Despite intense scientific scrutiny since the outbreak of variant Creutzfeldt-Jakob disease (vCJD) in the mid-1990s, no effective treatment is available for human prion disease. The passive transfer of anti-PrP monoclonal antibodies (mAbs) in prion-infected mice has been demonstrated to extend the m...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2011
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.625641 |